Global Osteoporosis Drugs Market 2014-2018

Global Osteoporosis Drugs Market 2014-2018

Category : Pharmaceuticals
Published On : January  2014
Pages : 56



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Global Osteoporosis Drugs market to grow at a CAGR of 3.98 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing global aging population. The Global Osteoporosis Drugs market has also been witnessing the increasing awareness of bone health education. However, the multiple patent expiries could pose a challenge to the growth of this market. 
TechNavio's report, the Global Osteoporosis Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Osteoporosis Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space are Amgen Inc., Eli Lilly & Co., Merck & Co. Inc., and Novartis AG.
Other vendors mentioned in the report are Abiogen Pharma SpA, F. Hoffmann La Roche Ltd., GlaxoSmithKline plc, Ligand Pharmaceuticals Inc., NPS Pharma Inc., and Pfizer Inc.
Key questions answered in this report: 
What will the market size be in 2016/2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

 

 

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report


03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape


06.1 Market Overview

06.2 Market Size and Forecast

06.3 Osteoporosis Drugs Market in the US

06.3.1 Market Size and Forecast

06.4 Osteoporosis Drugs Market in Europe

06.4.1 Market Size and Forecast

06.5 Five Forces Analysis

07. Market Segmentation by Drug Class

08. Geographical Segmentation


08.1 Osteoporosis Drugs Market in the Americas

08.2 Osteoporosis Drugs Market in the EMEA Region

08.3 Osteoporosis Drugs Market in the APAC Region

09. Buying Criteria

10. Rate of Incidence and Prevalence

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape


17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Market Share Analysis 2013

17.3 Other Prominent Vendors

18. Key Vendor Analysis

18.1 Amgen Inc.

18.1.1 Business Overview

18.1.2 Key Information

18.1.3 SWOT Analysis

18.2 Eli Lilly & Co.

18.2.1 Business Overview

18.2.2 Key Information

18.2.3 SWOT Analysis

18.3 Merck & Co. Inc.

18.3.1 Business Overview

18.3.2 Business Segmentation

18.3.3 Key Information

18.3.4 SWOT Analysis

18.4 Novartis AG

18.4.1 Business Overview

18.4.2 Business Segmentation

18.4.3 Key Information

18.4.4 SWOT Analysis

19. Other Reports in this Series



List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Osteoporosis Drugs Market 2013-2018 (US$ billion)

Exhibit 3: Osteoporosis Drugs Market in the US  2013-2018 (US$ billion)

Exhibit 4: Osteoporosis Drugs Market in Europe 2013-2018 (US$ billion)

Exhibit 5: Global Osteoporosis Drugs Market Segmentation by Drug Class

Exhibit 6: Global Osteoporosis Drugs Market by Geographical Segmentation 2013

Exhibit 7: Osteoporosis Drugs Market in the Americas 2013-2018 (US$ billion)

Exhibit 8: Osteoporosis Drugs Market in the EMEA Region 2013-2018 (US$ billion)

Exhibit 9: Osteoporosis Drugs Market in the APAC Region 2013-2018 (US$ billion)

Exhibit 10: Global Osteoporosis Drugs Market by Geographical Segmentation (percentage)

Exhibit 11: Comparison of YOY Growth Rate by Region for Global Osteoporosis Market 2013-2018

Exhibit 12: Business Segmentation of Merck & Co. Inc.

Exhibit 13: Business Segmentation of Novartis AG



Enquiry Before Buy